NASDAQ
Cynata Therapeutics Limited (CYYNF) has a revenue compound annual growth rate of -23.10% over 5 years and 20.77% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.